Helpful tips

How long is maintenance treatment for multiple myeloma?

How long is maintenance treatment for multiple myeloma?

The median duration of lenalidomide maintenance was 21 months, with 25% of patients receiving <11 months of maintenance and 25% with treatment longer than 31 months. The treatment had been discontinued in 64.7% (n = 90) of the patients when the analysis was performed.

Is Revlimid a maintenance drug?

Revlimid (lenalidomide) Revlimid is an oral medication that can stop or slow the growth of cancerous myeloma cells within the bone marrow. Despite the increased risk of causing new cancers in some patients Revlimid continues to be widely used as maintenance therapy in multiple myeloma.

What is the maintenance treatment for multiple myeloma?

Targeted therapy is the main type of maintenance therapy for multiple myeloma. Targeted therapy drugs used as maintenance therapy include: lenalidomide (Revlimid) bortezomib (Velcade)

How do you maintain myeloma in remission?

Chemotherapy and other treatments kill multiple myeloma cells and put you into remission, which means your tests no longer show any signs of cancer. Relapsed or recurrent multiple myeloma is when the cancer comes back after you were in remission.

How long does it take to recover from a stem cell transplant for multiple myeloma?

You can go home after a couple of weeks, when your counts are high enough to fight infection and prevent bleeding. Or your doctor may tell you to visit the transplant center daily for checkups. It can take 6 months or longer to fully recover from a transplant.

Can multiple myeloma be cured naturally?

There are no proven special diets to treat multiple myeloma. However, there are specific nutrition strategies that can be used to treat common symptoms, such as kidney damage and anemia, as well as to reduce cancer recurrence.

Is multiple myeloma curable 2020?

Multiple myeloma is a type of blood cancer for which there is no cure. In 2020, of all patients newly diagnosed with a blood cancer, 18% are expected to be diagnosed with this type of blood cancer. Depending on the stage, the average survival rate is five to seven years.

How long is Velcade treatment for multiple myeloma?

Velcade is given for nine 6-week treatment cycles.

What are the IMWG criteria for multiple myeloma?

The revised IMWG criteria allow, in addition to the classic CRAB features, three myeloma defining events (MDEs). The presence of at least one of these markers is considered sufficient for a diagnosis of multiple myeloma, regardless of the presence or absence of symptoms or CRAB features.

What are the criteria for smoldering multiple myeloma?

Definition. Smoldering Multiple Myeloma. Both criteria must be met: Serum monoclonal protein (IgG or IgA) ≥ 30g/L or urinary monoclonal protein ≥ 500mg per 24h and/or clonal bone marrow plasma cells 10-60%. Absence of myeloma-defining events or amyloidosis.

What are the CRAB criteria for multiple myeloma?

For decades the diagnosis of multiple myeloma required the presence of end-organ damage known as the CRAB criteria, including increased calcium level, renal dysfunction, anemia, and destructive bone lesions.The updated criteria allow for treatment…

What does it mean to have multiple myeloma?

Multiple myeloma is a cancer of the bone marrow plasma cells. It is synonymous with “myeloma” and “plasma cell myeloma.”. Plasma cells make antibodies against infectious agents such as viruses and bacteria. A cancerous or malignant plasma cell is called a myeloma cell.